The aim of this research was to explore the speculation that PX derivatives possess antiparkinsonian properties and to screen and evaluate these PX derivatives as dual A2AR antagonists/MAO-B inhibitors for treatment of Parkinson′s disease. This evidence concerns the gene MAOB and Parkinson disease.